MA42148A - USING PRG4 TO IMPROVE DYNAMIC VISUAL ACUITY AND HIGHER ORDER ABERRATIONS - Google Patents

USING PRG4 TO IMPROVE DYNAMIC VISUAL ACUITY AND HIGHER ORDER ABERRATIONS

Info

Publication number
MA42148A
MA42148A MA042148A MA42148A MA42148A MA 42148 A MA42148 A MA 42148A MA 042148 A MA042148 A MA 042148A MA 42148 A MA42148 A MA 42148A MA 42148 A MA42148 A MA 42148A
Authority
MA
Morocco
Prior art keywords
prg4
higher order
visual acuity
order aberrations
dynamic visual
Prior art date
Application number
MA042148A
Other languages
French (fr)
Inventor
Benjamin D Sullivan
Edward R Truitt
Original Assignee
Lubris Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubris Llc filed Critical Lubris Llc
Publication of MA42148A publication Critical patent/MA42148A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Prostheses (AREA)
MA042148A 2015-05-19 2016-05-19 USING PRG4 TO IMPROVE DYNAMIC VISUAL ACUITY AND HIGHER ORDER ABERRATIONS MA42148A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562163753P 2015-05-19 2015-05-19

Publications (1)

Publication Number Publication Date
MA42148A true MA42148A (en) 2018-04-04

Family

ID=57320651

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042148A MA42148A (en) 2015-05-19 2016-05-19 USING PRG4 TO IMPROVE DYNAMIC VISUAL ACUITY AND HIGHER ORDER ABERRATIONS

Country Status (14)

Country Link
US (1) US11666529B2 (en)
EP (1) EP3300482B1 (en)
JP (2) JP7291459B2 (en)
CY (1) CY1124538T1 (en)
DK (1) DK3300482T3 (en)
ES (1) ES2893304T3 (en)
HR (1) HRP20211589T1 (en)
HU (1) HUE056409T2 (en)
LT (1) LT3300482T (en)
MA (1) MA42148A (en)
PL (1) PL3300482T3 (en)
PT (1) PT3300482T (en)
SI (1) SI3300482T1 (en)
WO (1) WO2016187414A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015060935A1 (en) 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
KR20170123619A (en) 2015-01-26 2017-11-08 루브리스 엘엘씨 Uses of PRG4 as an anti-inflammatory agent
BR112020025148A2 (en) * 2018-06-21 2021-03-09 Lubris Llc LUBRICINE FOR USE IN WOUND HEALING
US20220127319A1 (en) * 2019-01-15 2022-04-28 Cornell University Recombinant mucins, and compositions and methods for using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
US20060240037A1 (en) 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
US20090155200A1 (en) 2004-04-20 2009-06-18 Jay Gregory D Methods of promoting cartilage healing or cartilage integration
JP2008507553A (en) 2004-07-23 2008-03-13 ミューコサル セラピューティクス リミテッド ライアビリディ カンパニー Compositions and methods for viscous replenishment
EP1827478A4 (en) 2004-12-03 2009-08-05 Mucosal Therapeutics Llc Methods of treatment for injured or diseased joints
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8144631B2 (en) 2006-12-13 2012-03-27 Cisco Technology, Inc. Interconnecting IP video endpoints with reduced H.320 call setup time
WO2008143816A1 (en) 2007-05-15 2008-11-27 Mucosal Therapeutics Compositions and methods for reducing friction between the surface of tendons or other soft tissues
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
SI2915529T1 (en) 2008-05-07 2017-09-29 The Regents Of The University Of California Therapeutic replenishment and enrichment of ocular surface lubrication
CN102438645A (en) 2009-01-13 2012-05-02 卢布里斯有限责任公司 Therapeutic modulation of vaginal epithelium boundary lubrication
EP2432492B1 (en) 2009-05-22 2014-12-24 Lubris, Llc Application and uses of prg4 and therapeutic modulation thereof
US9107885B2 (en) 2009-08-13 2015-08-18 Lubris Llc PRG4 treatment for interstitial cystitis
EP2525805B1 (en) 2010-01-19 2017-03-15 Lubris LLC Oral care compositions and methods
US8480227B2 (en) 2010-07-30 2013-07-09 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
WO2015060935A1 (en) * 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
ES2913061T3 (en) 2013-11-26 2022-05-31 Lubris Llc Compositions and methods for inhibiting intercellular interactions
US20180161393A1 (en) 2015-01-26 2018-06-14 Lubris Llc Prg4 for treating gout and its symptoms
KR20170123619A (en) 2015-01-26 2017-11-08 루브리스 엘엘씨 Uses of PRG4 as an anti-inflammatory agent
US20170312335A1 (en) 2015-12-30 2017-11-02 Lubris Llc Topical use of prg4 for treatment of allergy and symptoms of inflammation

Also Published As

Publication number Publication date
PT3300482T (en) 2021-10-15
EP3300482A1 (en) 2018-04-04
EP3300482B1 (en) 2021-07-14
ES2893304T3 (en) 2022-02-08
SI3300482T1 (en) 2021-11-30
PL3300482T3 (en) 2022-01-03
WO2016187414A1 (en) 2016-11-24
JP2018515534A (en) 2018-06-14
HUE056409T2 (en) 2022-02-28
LT3300482T (en) 2021-10-25
JP2021167318A (en) 2021-10-21
US20180140546A1 (en) 2018-05-24
US11666529B2 (en) 2023-06-06
JP7291459B2 (en) 2023-06-15
HRP20211589T1 (en) 2022-01-07
CY1124538T1 (en) 2022-07-22
DK3300482T3 (en) 2021-10-18
EP3300482A4 (en) 2019-02-13

Similar Documents

Publication Publication Date Title
MA43387A (en) ANTI-GITR ANTIBODIES AND THEIR METHODS OF USE
MA44955A (en) ANTI-TAU BODIES AND THEIR METHODS OF USE
MA41028A (en) METHODS AND FORMULATIONS FOR THE TREATMENT OF VASCULAR EYE PATHOLOGIES
MA42243A (en) FACTOR XI ANTIBODIES AND METHODS OF USE
MA40008A (en) ANTAGONIST ACTRII FOR THE TREATMENT AND PREVENTION OF SKIN ULCER IN A SUBJECT WITH ANEMIA
ITUB20152211A1 (en) DEVICE AND METHOD TO SEPARATE THE SOLID FRACTION FROM THE LIQUID FRACTION OF A TURBID
MA46963A (en) METHODS FOR DETERMINING THE DOSAGE OF CAR-T CELLS
FR3016371B1 (en) MODIFIED YEASTS TO USE CARBON DIOXIDE
MA43361A (en) COMPOSITION FOR THE CARE AND PROTECTION OF CROPS
MA54716A (en) REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS
MA42118A (en) BENZAMIDES SUBSTITUTED AND THEIR METHODS OF USE
FR2999428B1 (en) CHITINE OR CHIENE DERIVATIVES FOR USE IN THE PREVENTION AND / OR TREATMENT OF PARASITOSES
MA53991A (en) C1 ESTERASE INHIBITOR FUSION PROTEINS AND THEIR USES
MA52644A (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF DGLA ACID AND THEIR USE
MA50678A (en) IL-21 SPECIFIC BINDING MOLECULES AND THEIR USES
MA42148A (en) USING PRG4 TO IMPROVE DYNAMIC VISUAL ACUITY AND HIGHER ORDER ABERRATIONS
MA44968A (en) OXABOROLE ESTERS AND THEIR USES
FR2999191B1 (en) PROBIOTIC STRAINS FOR THE TREATMENT AND / OR PREVENTION OF DIARRHEA
DK3445331T3 (en) PHARMACEUTICAL OPHTHALMIC COMPOSITIONS WITHOUT PRESERVATIVES
BR112017010940A2 (en) liquid skin cleanser
FR3039166B1 (en) CD34 + CD41DIM MEGACARYOCYTE PROGENITORS AND USES THEREOF TO PRODUCE PLAQUETTES AND / OR MK CARRIING PROPLAQUETS
GB2560494B (en) Improvements in or relating to optical devices
FR3020452B3 (en) STORAGE AND CONSERVATION MODULE, IN ADDITION TO THE CONTINUOUS STUDY MODULE
FR3017536B1 (en) COMPOSITIONS FOR THE PREVENTION AND / OR TREATMENT OF ALPHA GLUCOSIDASE PATHOLOGIES
MA43834A (en) COMBINATION TO TREAT PAIN